Latest Leverage News

Altamin Limited has locked in a $2 million unsecured loan facility from its major shareholder Victor Smorgon Group, providing non-dilutive funding to advance its Lazio and Gorno projects and shore up working capital.

Western Mines Group has completed a $2.7 million placement to fund seismic surveys and drilling at its Mulga Tank nickel-cobalt-copper project, with a final tranche of shares pending shareholder approval.

Dome Gold Mines (ASX:DME) is raising up to AUD 2 million through unsecured convertible notes to accelerate its Sigatoka feasibility study, mining lease application, and copper-gold exploration amid rising metal prices.

Harris Technology’s refurbished tech division surpassed $1 million in monthly sales for the first time in July 2026, nearly doubling year-on-year revenue and becoming the company’s main earnings driver.

Clarity Pharmaceuticals has presented compelling clinical evidence that its investigational 64Cu-SAR-bisPSMA diagnostic and 67Cu-SAR-bisPSMA therapeutic candidates outperform current standards in prostate cancer care, positioning the company for regulatory and commercial milestones.

Flynn Gold has inked a non-binding Ore Purchase Agreement with Kaiser Reef's Henty Gold Mine, opening a potential low-capital route to production for its Golden Ridge project in Tasmania.

Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.

Godolphin Resources intensifies exploration at Mt Aubrey and Copper Hill East, leveraging a streamlined portfolio and a strategic pivot to precious and base metals in NSW’s Lachlan Fold Belt.

Evolution Mining plans to release its FY26 financial results on 19 August, highlighting 715koz gold and 66kt copper production with robust cash flow and cost metrics.

Aura Consolidated Group delivers strong pro forma Q2 2026 results with 27% revenue growth and a 51% improvement in adjusted EBITDA following its acquisition of Qoria.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Adavale Resources has reinforced the continuity of gold mineralisation beneath its London-Victoria open pit, reporting significant drill intercepts including 31m at 1.29g/t Au just 16m below the pit floor, underpinning near-term production prospects and a forthcoming resource update.